Primary |
Asthma |
16.7% |
Lichen Sclerosus |
16.7% |
Product Used For Unknown Indication |
16.7% |
Psoriasis |
16.7% |
Rhinitis Allergic |
16.7% |
Vaginal Disorder |
16.7% |
|
Application Site Pain |
25.0% |
Drug Ineffective |
25.0% |
Skin Injury |
25.0% |
Swelling Face |
25.0% |
|
Secondary |
Acrodermatitis |
20.0% |
Gastric Ulcer |
20.0% |
Migraine |
20.0% |
Multiple Allergies |
20.0% |
Panic Attack |
20.0% |
|
Gastric Haemorrhage |
50.0% |
Therapeutic Response Unexpected With Drug Substitution |
50.0% |
|
Concomitant |
Drug Use For Unknown Indication |
17.5% |
Product Used For Unknown Indication |
16.5% |
Psoriasis |
14.3% |
Acne |
7.8% |
Psoriatic Arthropathy |
5.0% |
Eczema |
4.8% |
Crohn's Disease |
4.4% |
Resorption Bone Increased |
4.4% |
Pain |
3.4% |
Migraine |
2.8% |
Nausea |
2.6% |
Constipation |
2.4% |
Hypertension |
2.4% |
Anxiety |
2.2% |
Hiv Infection |
2.0% |
Back Pain |
1.6% |
Depression |
1.6% |
Tinea Infection |
1.6% |
Asthma |
1.4% |
Rheumatoid Arthritis |
1.4% |
|
Osteopenia |
14.8% |
Uterine Prolapse |
11.1% |
Tooth Extraction |
8.6% |
Keratoconjunctivitis Sicca |
4.9% |
Pain In Extremity |
4.9% |
Thyroid Cancer |
4.9% |
Ventricular Dysfunction |
4.9% |
Vomiting |
4.9% |
White Blood Cell Count Increased |
4.9% |
Pain |
3.7% |
Rheumatoid Factor Positive |
3.7% |
Sunburn |
3.7% |
Thrombophlebitis Superficial |
3.7% |
Thyroid Disorder |
3.7% |
Weight Decreased |
3.7% |
Weight Increased |
3.7% |
Cardiac Disorder |
2.5% |
Disease Progression |
2.5% |
Hepatitis |
2.5% |
Nausea |
2.5% |
|